(2S,5S,12S,22S,23R)-2-((S)-2-((1S,2S)-2-((S)-2-((S)-2-((3S,4R)-4-((3S,6S,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39S,42S)-1-((1S,2S)-2-((S)-2-((S)-2-((1S,2S)-2-((S)-2-acetamido-3-(1H-imidazol-5-yl)propanamido)cyclopentanecarboxamido)-3-carboxypropanamido)propanamido)cyclopentyl)-12-(2-amino-2-oxoethyl)-33-(3-amino-3-oxopropyl)-21,30-bis(4-aminobutyl)-3-benzyl-9-(2-carboxyethyl)-27-(3-guanidinopropyl)-15-(4-hydroxybenzyl)-6,18-bis((R)-1-hydroxyethyl)-24,36-diisobutyl-39,42-dimethyl-1,4,7,10,13,16,19,22,25,28,31,34,37,40-tetradecaoxo-2,5,8,11,14,17,20,23,26,29,32,35,38,41-tetradecaazatritetracontanamido)pyrrolidine-3-carboxamido)-6-aminohexanamido)-3-(4-hydroxyphenyl)propanamido)cyclopentanecarboxamido)-4-amino-4-oxobutanamido)-8,12-bis(4-aminobutyl)-23-hydroxy-5-isobutyl-3,6,10,13,16,20-hexaoxo-4,7,11,14,17,21-hexaazatetracosane-1,22-dicarboxylic acid

ID: ALA4282016

Chembl Id: CHEMBL4282016

PubChem CID: 145979957

Max Phase: Preclinical

Molecular Formula: C165H261N45O47

Molecular Weight: 3627.17

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H]1CNC[C@@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H]1CCC[C@@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)NC(CCCCN)CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)NCCC(=O)N[C@H](C(=O)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O

Standard InChI:  InChI=1S/C165H261N45O47/c1-82(2)65-113(151(243)183-85(7)137(229)182-86(8)139(231)207-124-79-176-78-102(124)143(235)191-107(38-19-24-60-168)147(239)203-116(69-93-45-49-97(215)50-46-93)155(247)189-104-42-28-35-100(104)141(233)198-120(73-126(172)218)157(249)206-123(76-133(227)228)159(251)202-114(66-83(3)4)153(245)186-95(33-17-22-58-166)72-129(221)187-106(37-18-23-59-167)144(236)180-80-130(222)178-64-57-128(220)208-136(90(12)213)164(256)257)200-149(241)111(53-55-125(171)217)194-145(237)108(39-20-25-61-169)192-146(238)110(44-30-63-179-165(174)175)193-154(246)115(67-84(5)6)201-148(240)109(40-21-26-62-170)195-162(254)134(88(10)211)210-161(253)118(70-94-47-51-98(216)52-48-94)204-158(250)121(74-127(173)219)205-150(242)112(54-56-131(223)224)196-163(255)135(89(11)212)209-160(252)117(68-92-31-15-14-16-32-92)197-140(232)99-34-27-41-103(99)188-138(230)87(9)184-152(244)122(75-132(225)226)199-142(234)101-36-29-43-105(101)190-156(248)119(185-91(13)214)71-96-77-177-81-181-96/h14-16,31-32,45-52,77,81-90,95,99-124,134-136,176,211-213,215-216H,17-30,33-44,53-76,78-80,166-170H2,1-13H3,(H2,171,217)(H2,172,218)(H2,173,219)(H,177,181)(H,178,222)(H,180,236)(H,182,229)(H,183,243)(H,184,244)(H,185,214)(H,186,245)(H,187,221)(H,188,230)(H,189,247)(H,190,248)(H,191,235)(H,192,238)(H,193,246)(H,194,237)(H,195,254)(H,196,255)(H,197,232)(H,198,233)(H,199,234)(H,200,241)(H,201,240)(H,202,251)(H,203,239)(H,204,250)(H,205,242)(H,206,249)(H,207,231)(H,208,220)(H,209,252)(H,210,253)(H,223,224)(H,225,226)(H,227,228)(H,256,257)(H4,174,175,179)/t85-,86-,87-,88+,89+,90+,95?,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120-,121-,122-,123-,124-,134-,135-,136-/m0/s1

Standard InChI Key:  KMQMFGLYVIBYJN-ZSHGJUGYSA-N

Alternative Forms

  1. Parent:

    ALA4282016

    ---

Associated Targets(Human)

CTRC Tchem Chymotrypsin (134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DPP4 Tclin Dipeptidyl peptidase IV (7109 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VIPR2 Tchem Vasoactive intestinal polypeptide receptor 2 (744 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
VIPR1 Tchem Vasoactive intestinal polypeptide receptor 1 (1904 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PROK Proteinase K (22 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 3627.17Molecular Weight (Monoisotopic): 3624.9417AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1.  (2016)  Peptides comprising non-natural amino acids and methods of making and using the same, 

Source